Related Subjects:
|Hypertension
|Acute Heart Failure
|Chronic Heart Failure
- ๐น Angiotensin II receptor blocker (ARB) โ primarily AT1 antagonist.
โ๏ธ Action
- There are two angiotensin II receptors: AT1 and AT2.
- ๐ฉธ AT1 receptor โ vasoconstriction + aldosterone release.
- ๐ซ Losartan blocks AT1 receptor โ vasodilation + reduced aldosterone.
- ๐ Results in lower blood pressure and reduced afterload.
- โน๏ธ Losartan is a prodrug, converted to active metabolite by the liver.
๐ฏ Indications / Dose
- โค๏ธ Hypertension.
- ๐ Heart failure with reduced ejection fraction.
- ๐งช Prevention and treatment of diabetic nephropathy (especially with proteinuria).
- โก๏ธ Typical initiation: Losartan 25โ50 mg PO OD.
- โก๏ธ Maintenance range: titrate up slowly to max 100 mg PO OD (adjusted for renal function and BP).
โ Contraindications
- ๐ซ Pregnancy โ teratogenic, risk of birth defects.
- โ ๏ธ Severe aortic stenosis or hypertrophic cardiomyopathy (risk of collapse).
- โ ๏ธ Bilateral renal artery stenosis or severe renal impairment (risk of renal failure).
๐ Interactions
- May be used instead of or with ACE inhibitors (avoid dual blockade unless specialist indication).
- โฌ๏ธ Risk of hyperkalaemia with potassium-sparing diuretics, supplements, or ARBs/ACEI combinations.
โ ๏ธ Side Effects
- ๐งช Hyperkalaemia (monitor Kโบ, particularly in CKD).
- ๐จ Unlike ACE inhibitors, not typically associated with cough.
- Rare: dizziness, hypotension, renal impairment.
๐ Monitoring
- ๐ Check renal function and electrolytes 4 days and 2 weeks after initiation.
- ๐ Recheck 1 week after any dose increase.
- โ ๏ธ Stop or reduce if creatinine โ >30% or Kโบ >6.0 mmol/L.